Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gofire was a medical technology company that developed a smart, metered-dose inhaler designed for the precise delivery of plant-based medicines, primarily medical cannabis and CBD. The company's platform integrated a proprietary hardware device with a mobile application, enabling patients to track their dosage, chemical profiles, and therapeutic outcomes in real-time. By providing data-driven insights into how specific formulations affected individual users, Gofire aimed to standardize the consumption of alternative medicines and improve patient care through precision dosing. The technology was designed to ensure consistency and accountability for both patients and healthcare providers. Although the company reached the commercial stage, it ceased operations around 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gofire.